INTRODUCTION
Stem cells can self-renew and differentiate into specialized cells of various tissues [1] . Therefore, these cells, for example, embryonic stem cells (ESCs), induced pluripotent stem cells (iPSCs), hematopoietic stem cells, and mesenchymal stem cells (MSCs), have been the object of basic research and clinical applications. Among these types of stem cells, MSCs, as represented by adipose-derived stem/stromal cells (ADSCs) and bone marrow-derived stem/stromal cells (BMSCs), have been recognized as useful material for cell-based therapy [2] . MSCs have been isolated from various tissues, including adipose tissue, the bone marrow, peripheral blood, cord blood, the liver, dental pulp, and fetal tissue; of these, adipose tissue is one of the most abundant source of MSCs [3] . ADSCs possess multipotency and have the potential to differentiate into cell types such as adipocytes, osteocytes, chondrocytes, neurons, vascular endothelial cells, cardiomyocytes, myoblasts, and islet β-cells under appropriate conditions [4] . The researches have suggested that ADSCs are heterogeneous and comprise phenotypically and/or functionally different subpopulations [5] [6] [7] . For example, the cluster of differentiation (CD)73 + subpopulation of murine ADSCs possesses increased potential for cardiomyocyte differentiation [6] . The CD90 + subpopulation of murine ADSCs has higher tube-forming ability than the CD90 -subpopulation, which has high adipogenic potential [8] . The CD90 + subpopulation also exhibits higher efficiency of iPSC induction than the CD90 -subpopulation [5] . Human ADSCs also include the CD105 Lo subpopulation, which has high osteogenic potential [7] . Some studies have identified different subpopulations in ADSCs on the basis of surface antigen markers [5] [6] [7] . However, it is unclear how these markers (e.g., CD90 and CD105) are functionally related to cell differentiation.
In mice, aldehyde dehydrogenase (ALDH) is a superfamily comprising 20 intracellular enzymes and is responsible for the oxidization of various aldehydes [9] . High ALDH activity has been shown in normal hematopoietic stem cells, neural stem cells, and cancer stem cells in various types of neoplastic diseases [10] . Therefore, high ALDH activity is considered to be a common marker for normal and malignant stem cells. In human ADSCs, however, only one study has been performed on the ALDH Hi subpopulation, whose significance in differentiation potential is unclear [11] . Moreover, to our knowledge, the existence of the ALDH Hi subpopulation within murine 
MATERIALS AND METHODS

Animals and ADSC isolation
C57BL/6J mice were purchased from Kyudo Co., Ltd (Saga, Japan). All animal experiments were carried out in accordance with the National Institutes of Health guide for the care and use of Laboratory animals (NIH Publications No. 8023, revised 1978) and the institutional guidelines of Yamaguchi University. The animal experiments were approved by the institutional animal experiment ethics committee of Yamaguchi University. Murine ADSCs were isolated from twenty of C57BL/6J female mice of 4-to 6-wk-old, as previously described [8] . Briefly, the subcutaneous adipose tissue was resected, washed with Dulbecco's phosphate-buffered saline (DPBS; Wako, Osaka, Japan), and cut into small pieces. The adipose tissue pieces were digested in high glucose Dulbecco's modified Eagle's medium (DMEM; Wako, Osaka, Japan) containing 1.0 mg/mL collagenase type Ⅰ (Sigma-Aldrich, St. Louis, MO, United States), 10% fetal bovine serum (FBS; Sigma-Aldrich), and antibiotic-antimycotic agents (PSM; penicillin: 100 U/mL, streptomycin: 100 µg/mL, and amphotericin B: 0.25 µg/ mL, final concentrations; Nacalai Tesque, Kyoto, Japan), using a shaking incubator at 37.5 ℃ and 250 rpm for 1 h.
The digested tissue was filtered through a sterile ø100-µm nylon mesh (EASYstrainer, 100 µm; Greiner Bio-One Japan, Tokyo, Japan), followed by centrifugation at 400 × g for 5 min in DPBS supplemented with 1% FBS and 1 mmol/L EDTA•3Na (Wako, Osaka, Japan). The pellet was resuspended in DMEM supplemented with 10% FBS and antibacterial/antimycotic agent and was cultured at 37.0 ℃ in a 5% CO2 atmosphere, using ø10 cm dish (Corning, NY, United States). When the cultures reached 80%-90% confluence, the ADSCs were dissociated from the dish by using Accutase solution (Innovative Cell Technologies, San Diego, United States), and seeded into new dishes.
Flow cytometry analysis
Adherent ADSCs from passage 4 were dissociated using Accutase solution; 1 × 10 6 cells were resuspended and incubated for 5 min on ice with 2 µL of anti-mouse CD16/32 rat monoclonal antibody (BioLegend, San Diego, CA, United States). Cells were stained with 1 µL viability probe (Zombie NIR, Biolegend) for 20 min at room temperature to stain dead cells. ALDH activity was assessed by utilizing the ALDEFLUOR kit (Stemcell Technologies, Vancouver, Canada) according to the manufacturer's instructions. Briefly, 1 × 10 6 cells were resuspended in 1 mL assay buffer and 5 µL ALDEFLUOR reagent was added after thorough mixing; then, 0.5 mL of the cell suspension was transferred to a new tube with 5 µL diethylaminobenzaldehyde (DEAB) reagent (ALDH inhibitor) for negative control of ALDH activity. Flow cytometric analysis and cell sorting were performed using Accuri C6 (BD Bioscience, San Jose, CA, United States) and the SH800 cell sorter (Sony, Tokyo, Japan). Flow cytometric data were analyzed with the FlowJo (Tree Star, Ashland, OR, United States) software. /well) were cultured at 37 ℃ in a 5% CO2
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atmosphere in a 96-well plate in 100 µL adipogenic differentiation medium composed of α-minimal essential medium (αMEM) supplemented with 10% FBS, 1% PSM, L-glutamine, and 50 µL adipogenic supplement containing hydrocortisone, isobutylmethylxanthine, and indomethacin for 15 d in 37 ℃ and a 5% CO2 atmosphere.
For osteogenic differentiation, cells were cultured in osteogenic differentiation medium composed of 5 mL α-MEM basal medium and 250 µL osteogenic supplement containing ascorbate-phosphate, β-glycerolphosphate, and recombinant human bone morphogenetic protein-2 for 15 d in 37 ℃ and a 5% CO2 atmosphere. The medium was replaced every 2-3 d.
To assess adipogenic and osteogenic differentiation by immunocytochemistry, cultured cells were fixed in 4% paraformaldehyde phosphate buffer solution (Wako, Osaka, Japan) for 20 min. After the cells were washed with DPBS, they were permeabilized and blocked with DPBS supplemented with 0.3% Triton X-100 (Sigma-Aldrich), and 10% FBS for 45 min. The cells were subsequently incubated for 1 h in DPBS containing 10 µg/mL goat anti-mouse fatty acid binding protein (FABP) 4 polyclonal antibody to label adipocytes or were incubated with 10 µg/mL goat anti-mouse osteopontin polyclonal antibody to label osteocytes. They were then washed with DPBS and incubated for 1 h in DPBS containing phycoerythrin (PE)-conjugated rabbit anti-goat IgG antibody [rabbit F(ab')2 anti-goat IgG-H and L (PE), pre-adsorbed, Abcam, Cambridge, United Kingdom]. Nuclei were stained with 5 µg/mL Hoechst 33342 (Dojindo Laboratories, Kumamoto, Japan). Photographs were obtained and analyzed using a fluorescence microscope (BZ-9000; Keyence, Osaka, Japan) and its analysis software.
Gene expression array analysis and GSEA
Gene expression array analysis and GSEA were performed on the published gene expression profile of C57BL/6 mice divided by ALDH hi and ALDH lo subpopulations of ADSCs. About 3 × 10 6 cells from each subpopulation were lysed and total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). Cyanine-3 (Cy3)-labeled cRNA was prepared from 0.1 µg total RNA by using the Low Input Quick Amp Labeling Kit (Agilent Technologies, Santa Clara, CA, United States) according to the manufacturer's instructions; this was followed by RNeasy column purification (Qiagen). Dye incorporation and cRNA yield were checked with the NanoDrop Microarray Scanner (G2600D), using one color scan setting for 8 × 60 k array slides (scan area, 61 × 21.6 mm; scan resolution, 3 µm; dye channel set for Green PMT was set to 100%). The scanned images were analyzed with Feature Extraction Software 11.5.1.1 (Agilent Technologies), using default parameters to obtain the subtracted background and spatially detrended Processed Signal intensities.
Statistical analysis
Statistical analysis was performed using GraphPad Prism version 6.01 for Windows (GraphPad Software, La Jolla, CA, United States). The results have been expressed in terms of mean ± SE. Comparisons of two groups were performed with the independent t-test. Multiple comparisons were performed with one-way analysis of variance. Data were considered statistically significant when the P value was ≤ 0.05.
RESULTS
ALDH activity of murine ADSCs
To identify the subpopulation defined by ALDH activity in murine ADSCs, single-cell suspensions of cultured murine ADSCs were stained using the ALDEFLUOR kit and analyzed with flow cytometry. A small subpopulation 
Cell differentiation to adipocytes and osteocytes
To assess the adipogenic and osteogenic differentiation potential of the two subpopulations, sorted ALDH (Figure 2A and B). Furthermore, immunofluorescence staining for osteopontin revealed that ADSCs that differentiated into osteocytes appeared as accumulated granules in the cytosol in each ALDH Hi and ALDH Lo subpopulation ( Figure   2C and D).
Evaluation of differentiation
Adipogenic and osteogenic differentiation of each ALDH Hi and ALDH Lo subpopulation was quantitatively assessed using the BZ-9000 microscope and its analysis software. Ten visual fields were taken randomly for every 3 wells, and the immunofluorescence-staining positive-areas in 30 visual fields were analyzed. Subsequently, the immunofluorescence-staining-positive area was divided by the Hoechst 33342-positive area for each of the 30 visual fields. The ALDH Hi subpopulation was found to have significantly more adipogenic and osteogenic relative-differentiationmarker-positive areas than the ALDH Lo subpopulation ( Figure   2E and F).
GSEA
To identify the sets of gene that were up-or downregulated in the ALDH Hi subpopulations, we performed GSEA for the published gene expression profile of C57BL/6 mice divided by the ALDH Hi and ALDH Lo subpopulations of ADSCs. Intriguingly, high gene set enrichment scores were obtained for the structural constituents of ribosomes ( Figure 3 ).
DISCUSSION
MSCs are reported to commonly express CD29, CD73, CD90, and CD105 and to be negative for markers such as CD45 and CD56 [12, 13] . There have been many studies on cell surface antigen markers of ADSCs, such as CD34 and CD44 [12, 14, 15] . Recently, however, studies have shown that some markers such as CD90 or CD105 are not expressed homogenously in bulk ADSC populations but are expressed in small ADSC subpopulations, suggesting that ADSCs are phenotypically heterogeneous [5, 7, 8] . In our current study, we detected ALDH activity as a stem cell marker in murine ADSCs. High ALDH activity has been reported as a marker for cells such as hematopoietic stem cells and cancer stem cells [10] . However, not many studies have been performed on ALDH activity and cell differentiation potential in MSCs. In one of these studies, Estes et al [11] showed the presence of a subpopulation Gene  RPS21  RPL5  FAU  RPS8  RPL9  RPS25  RPL7A  RPS15A  RPL39  RPL28  RPS2  RPS7  MRPS14  RPL23A  RPS9  RPS29  RPS13  RPS23  RPL14  RPS6  RPL35  RPS19  RPLP1  RPL19  RPL3  RPL34  RPL21  RPS17  RPS4X  RPL11  RPL27A  RPL22  RPL27  MRPL23  RPS18   RPL15  RPS10  RPS27  RPL6  RPS11  RPS5  RPS26  MRPS24  RPL31  RPS12  RPL8  RPL26  RPS24  RPLP2  RPL38  RPS16  RPL29  RPS20  MRPL52  RPS3  RPL24  RPS28  RPL4  RPL18A  RPL15  RPL30  RPLP0  RPL7  RPS14  MRPS7  MRPL51  RPL41  MRPL55  MRPS22  MRPS12  MRPL10  MRPL41 with high ALDH activity in human ADSCs; however, no difference was found in terms of differentiation potential. Relationships between ribosome biogenesis and stem cells have been described only recently. For example, it was reported that the transition from self-renewal to differentiation depends on the enhancement of ribosome biogenesis accompanied by increased protein synthesis in female Drosophila germline stem cells [16] . Slow growth, low biosynthesis and markedly reduced ribosome biogenesis were observed in hematopoietic stem cells that lacked RUNX1, which is known to promote the transcription of essential ribosome-related proteins [17] . We have few reports about relationship between ribosome biogenesis and MSCs. One of these reports presented one of core proteins of 60S ribosome is necessary for differentiation of osteocyte from MSCs [18] . In our current study, GSEA revealed the significant enrichment of ribosome-related genes in the ALDH Hi subpopulation compared to that in the ALDH Lo subpopulation, suggesting that ribosome biogenesis is part of the mechanism underlying the higher differentiation potential of the ALDH Hi subpopulation.
ADSCs can be obtained in a less invasive manner from adipose tissue. Therefore, ADSCs are considered to be a promising source of cell-based therapy in the clinical setting. ADSCs have already been used in clinical studies for cardiovascular disease, breast reconstruction after mastectomy, spinal cord injury, cirrhosis, renal insufficiency, skin fistula after surgery, and skin fistula with Crohn's disease [4, 19, 20] . Some of those trials reported the therapy to be safe and effective; however, there is obvious room for improvement. For instance, in a phase 3 trial for therapy with allogeneic expanded ADSCs for treatment-refractory complex perianal fistulas in patients with Crohn's disease (ADMIRE-CD trial), approximately 50% of patients who received ADSC-therapy experienced remissions [21] . Although this is a significant achievement, further research and development are required in relation to the patients who did not respond to this trial.
Purification of specific subpopulations and engineering of ADSCs into cells that are highly efficient in differentiating into specific tissues might help obtain basic knowledge for cell-based therapy, which is more specific to individual disease conditions of each organ for which ADSCs are used. Further investigation is required to identify the underlying mechanisms that regulate ribosome biogenesis and differentiation in ALDH Hi ADSCs.
In conclusion, we demonstrated that murine ADSCs 
COMMENTS
Background
Adipose-derived stem cells (ADSCs) are recognized as useful materials for regenerative therapy. Recent study revealed the existence of subpopulations in ADSCs by surface antigen markers. However, functions of these markers remain elusive. Aldehyde dehydrogenase (ALDH) activity is commonly used as functional marker to identify human and mouse hematopoietic stem cell, though there has been no report about identification of a subpopulation(s) in murine ADSCs using ALDH.
Research frontiers
Several surface antigen markers are reported to be capable of prospectively identifying distinct ADSCs subpopulations in human and murine. However, the function(s) of those reported markers are poorly understood. ALDH has its known function, such as a protective effect to hematopoietic stem cells through acetaldehyde detoxification, although it is not known in ADSCs.
